12/21
Headlines

Mark DeFrance

Mark DeFrance is a senior research analyst at Tech Insider, focusing on the enterprise software sector. Prior to joining TI, Mark covered enterprise software for First Albany, and prior to that he worked in equity research at B.T. Alex Brown and Bankers Trust. Mark has written software applications in various programming languages including BASIC, Pascal, and COBOL. He has also been recognized in The Wall Street Journal's "Best on the Street" survey and was recognized by Forbes Magazine as the No. 1 sell-side stock picker in the software industry for a five-year period, with returns of 115% versus 26% for the software industry.

Basic Material Most Active: Vale (NYSE:VALE), Petroleo Brasileiro Petrobras (NYSE:PBR), Barrick Gold (NYSE:ABX), Cabot Oil & Gas (NYSE:COG)

Mark DeFrance03 mins

Brazil’s Superior Justice Tribunal, the country’s second highest court, on Thursday ruled in favour of iron ore giant Vale SA (ADR) (NYSE:VALE) in a dispute over taxation of foreign subsidiaries. Reuters reports the court ruled 3 to 1 that Brazilian treaties with Belgium, Luxembourg and Denmark prevented Brazil from taxing the profits of Vale SA…

Read More

NASDAQ recent Insider Buying: Huntington Bancshares (NASDAQ:HBAN), American Realty Capital Properties (NASDAQ:ARCP), Zix Corporation (NASDAQ:ZIXI), The Wet Seal (NASDAQ:WTSL)

Mark DeFrance02 mins

Huntington Bancshares Incorporated (NASDAQ:HBAN) Director David L Porteous acquired 2,760 shares of the stock in a transaction dated Thursday, April 24th. The stock was purchased at an average cost of $9.40 per share, for a total transaction of $25,944.00. Huntington Bancshares Incorporated (NASDAQ:HBAN) stock performance was -1.27% in last session and finished the day at…

Read More

Mid Cap Recent Insider Buying: Opko Health Inc. (NYSE:OPK), Sears Holdings (NASDAQ:SHLD), Ares Capital Corporation (NASDAQ:ARCC), Esterline Technologies (NYSE:ESL)

Mark DeFrance02 mins

Opko Health (NYSE:OPK) CEO Phillip Md Et Al Frost bought 89,500 shares of the stock in a transaction dated Tuesday, April 22nd. The shares were purchased at an average price of $8.29 per share, for a total transaction of $741,955.00. Opko Health (NYSE:OPK) stock performance was -1.81% in last session and finished the day at…

Read More

Biotech Bearish Stocks: Infinity Pharmaceuticals Inc. (NASDAQ:INFI), Corcept Therapeutics Incorporated (NASDAQ:CORT), Puma Biotechnology Inc (NYSE:PBYI), Conatus Pharmaceuticals (NASDAQ:CNAT)

Mark DeFrance02 mins

A Palo Alto startup will focus an $18 million VC investment on developing a drug to stop unexplained recurrent miscarriages. Nora Therapeutics is capitalizing on work started by cofounder Darryl Carter at Johns Hopkins University that led to development of Nora’s lead drug, NT-100. Nora is led by CEO Jeff Tong, who had been vice…

Read More

Watch List: National Bank of Greece (NYSE:NBG), NGP Capital Resources Company (NASDAQ:NGPC), Weibo Corp (NASDAQ:WB), SINA Corp (NASDAQ:SINA)

Mark DeFrance02 mins

Greece’s second-biggest lender, the National Bank of Greece (ADR) (NYSE:NBG) has unveiled the terms of a planned share capital increase that must be approved by the shareholders’ general meeting on May 10. National Bank of Greece (ADR) (NYSE:NBG) stock performance was 0.23% in last session and finished the day at $4.44. Traded volume was 1.49million…

Read More
Gilead Sciences GILD NASDAQ:GILD

Recent Insider Buying: Molycorp Inc (NYSE:MCP), Callon Petroleum Company (NYSE:CPE), Opko Health (NYSE:OPK), Miller Energy Resources (NYSE:MILL)

Mark DeFrance02 mins

Molycorp Inc (NYSE:MCP) major shareholder Y Metales S.A. Molibdenos purchased 14,650,000 shares of the company’s stock in a transaction that occurred on 2014, March 5th. The shares were purchased at an average cost of $5.00 per share, with a total value of $73,250,000.00. Molycorp Inc (NYSE:MCP) stock performance was 4.00% in last session and finished…

Read More